10x Genomics, Inc. (TXG): Depreciation & Amortization
$36.20M
Year ended 2025-12-31
$39.98M
Trailing 12 months to 2026-06-30
+12.6%
3-year compound annual growth
+20.9%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $36.20M | +0.9% | 2026-02-13, From 2025-01-01 |
| 2024-12-31 | $35.88M | +1.0% | 2026-02-13, From 2024-01-01 |
| 2023-12-31 | $35.51M | +40.0% | 2026-02-13, From 2023-01-01 |
| 2022-12-31 | $25.37M | +20.1% | 2025-02-13, From 2022-01-01 |
| 2021-12-31 | $21.12M | +50.7% | 2024-02-15, From 2021-01-01 |
| 2020-12-31 | $14.01M | +98.3% | 2023-02-16, From 2020-01-01 |
| 2019-12-31 | $7.07M | +80.9% | 2022-02-18, From 2019-01-01 |
| 2018-12-31 | $3.90M | -9.3% | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | $4.30M | n/a | 2020-02-27, From 2017-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| 10x Genomics, Inc. (TXG) | 2025-12-31 | $36.20M | +0.9% |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | $7.58M | +5.1% |
| Bio-Rad Laboratories, Inc. (BIO) | 2025-12-31 | $165.40M | +9.1% |
| Revvity, Inc. (RVTY) | 2025-12-28 | $405.34M | -5.3% |
| Quanterix Corp (QTRX) | 2025-12-31 | $15.84M | +145.1% |
| Bruker Corp (BRKR) | 2025-12-31 | $220.30M | +19.9% |
| Illumina, Inc. (ILMN) | 2025-12-28 | $270.00M | -23.7% |
| Avantor, Inc. (AVTR) | 2025-12-31 | $410.20M | +1.2% |
| Agilent Technologies, Inc. (A) | 2025-10-31 | $288.00M | +12.1% |
Compare TXG, CTKB, BIO, RVTY side by side · Screen every company in Laboratory Analytical Instruments ↗